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Background and Purpose—Mitogen-activated protein kinases (MAPKs) are involved in vascular wall remodeling, but
their role in the pathogenesis of intracranial aneurysms (IAs) is poorly known. We investigated the expression and
phosphorylation of the 3 major mitogen-activated protein kinases, c-Jun N-terminal kinase (JNK), p38, and extracellular
signal-regulated kinase, in unruptured and ruptured human IAs.
Methods—Tissue samples (n24, 12 unruptured and 12 ruptured IAs) were obtained during microneurosurgical clipping.
The localization of the proteins was studied by immunofluorescent staining, and protein levels and phosphorylation state
were studied by Western blotting.
Results—The phosphorylation of p54 JNK was increased 1.5-fold in ruptured IAs and the phospho-p54 JNK level and its
phosphorylation state directly correlated with IA size. The levels of phosphorylated and total levels of p38 were
associated with IA size as well. Extracellular signal-regulated kinase did not associate with IA size or rupture status.
Expression of transcription factor c-Jun, a downstream target of JNK, correlated with p54 JNK level and phosphory-
lation state. Furthermore, the levels of matrix metalloproteinase 9, known to have a role in vessel wall degeneration,
correlated with p54 JNK phosphorylation in unruptured IAs and its expression was increased 4.3-fold in ruptured IAs.
Conclusions—Our results suggest that JNK activity and expression are involved in IA growth and possibly rupture and p38
expression in IA growth. Thus, pharmacological therapy affecting the stress-activated mitogen-activated protein kinases,
JNK and p38, may enhance the repair of the IA wall in the future. (Stroke. 2008;39:886-892.)
Key Words: extracellular signal-regulated MAP kinases  intracranial aneurysm  JNK mitogen-activated protein
kinases  p38 mitogen-activated protein kinases
Intracranial aneurysms (IAs) are the most common cause ofsubarachnoid hemorrhage with up to 50% case fatality.1
Risk factors for IA rupture include hypertension, smoking,
heavy alcohol consumption, and female gender.2,3 Some IAs
are familial.4 However, the mechanisms of how IAs develop
and why some of them rupture remain unclear, although
histological differences in ruptured and unruptured aneu-
rysms have been observed. Vascular remodeling, increased
inflammatory cell infiltration, complement activation, and
apoptosis associate with the rupture of IAs.5–8
Mitogen-activated protein kinases (MAPKs) are a family
of intracellular signaling proteins consisting of c-Jun
N-terminal kinases (JNKs), p38 MAPKs, and extracellular
signal-regulated kinases (ERKs). They respond to various
extracellular stimuli such as inflammatory cytokines, growth
factors, mechanical stretch, and cellular stress. MAPKs have
a critical role in cell growth, proliferation, differentiation, and
apoptosis. They phosphorylate other protein kinases and
regulate various transcription factors that control the expres-
sion of large variety of genes. To be activated, MAPKs
must be phosphorylated by upstream kinases.9 MAPKs are
involved in vascular wall remodeling. In experimental ani-
mals, they are rapidly and transiently activated in balloon-
injured arteries, hypertrophied cardiac and hypertensive vas-
cular tissue, and have important roles in smooth muscle cell
(SMC) proliferation and neointimal formation.10–13 Interest-
ingly, JNK was recently shown to be involved in the
pathogenesis of abdominal aortic aneurysms where it acti-
vates transcription factor c-Jun and regulates the expression
of matrix metalloproteinases (MMPs) involved in vessel wall
degradation.14
The role of MAPKs in the pathogenesis of cerebral artery
aneurysms is poorly known. A previous immunohistochem-
istry study has suggested that the expression of phosphory-
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lated JNK (phospho-JNK) and its substrate c-Jun are in-
creased in the IA wall.15 We wanted to explore this
phenomenon using more quantitative methods and include
other MAPKs as well.
Our aim was to investigate the expression, phosphorylation
state, and localization of the 3 major MAPKs, namely JNK,
p38, and ERK, in unruptured and ruptured human IAs. The
samples were obtained at surgery and studied by Western
blotting (WB) and immunofluorescent staining.
Materials and Methods
Human Intracranial Aneurysm Samples
IA samples (n24; 12 unruptured and 12 ruptured) were obtained
during their microneurosurgical clipping. Cutting a part of the dome
followed by the coagulation of the remaining aneurysm was per-
formed to achieve optimal clipping of the aneurysm and to obtain
samples (J.H., M.N. Department of Neurosurgery, Helsinki Univer-
sity Central Hospital). Patient and IA characteristics, obtained from
the medical records, are described in Table 1. The IA samples were
immediately snap-frozen in liquid nitrogen and stored at70°C. The
study was approved by the local ethics committee of the Departments
of Neurology, Neurosurgery, Otorhinolaryngology, and Ophthalmol-
ogy at the Helsinki University Central Hospital.
Histology and Immunofluorescence
IA samples were cryosectioned at 4 m. For histology, sections were
fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS)
and stained with hematoxylin–eosin. For immunofluorescence, sec-
tions were fixed immediately in 4% formaldehyde (in PBS) for 15
minutes at room temperature. Sections were blocked in 5% normal
goat or horse serum (Vector Laboratories Inc, Burlingame, Calif)
diluted in 0.3% Triton X-100 (Sigma-Aldrich, St. Louis, Mo) in PBS
(PBS/Triton) for 60 minutes. After blocking, the sections were
incubated with the primary antibody against phospho-SAPK/JNK,
phospho-p38, and phospho-p44 MAPK (detailed in supplemental
Table I, available online at http://stroke.ahajournals.org) diluted in
PBS/Triton 30 minutes at room temperature and overnight at 4°C
followed by incubation with a fluorochrome-conjugated secondary
antibody diluted in PBS/Triton (supplemental Table I). For double
staining, an additional incubation with mouse monoclonal Cy3-
conjugated anti--smooth muscle actin antibody (1:1000 in PBS;
Sigma-Aldrich) 30 minutes at room temperature and overnight at
4°C was performed. Sections were mounted in Vectashield con-
taining DAPI (Vector Laboratories Inc). Rat balloon-injured aorta
served as a positive control tissue.16 For negative controls, the
primary antibody was omitted.
Preparation of Tissue Samples and Western
Blot Analysis
Tissue samples were pulverized in liquid nitrogen with mortar and
pestle, homogenized in hot 1% sodium dodecyl sulfate (SDS) in PBS
buffer, and sonicated. Samples were kept at 100°C for 10 minutes
and immediately frozen on dry ice. For WB, the mixture was
centrifuged at 14 000 g for 15 minutes at 4°C. The supernatant
protein concentrations were measured by DC-protein assay (Bio-Rad
Laboratories, Hercules, Calif) according to the manufacturer’s pro-
tocol. The samples were mixed (5:1) with sample buffer (0.3 mol/L
Tris, pH 6.8, 10% SDS, 5% -mercaptoethanol, 50% glycerol and
bromophenol blue). First, 20 g of protein was loaded for actin WB.
Actin served as an internal loading control to standardize the amount
of intracellular protein for each IA sample, resulting in 15 to 42 g
of total protein to be loaded per sample on subsequent gels. Proteins
were separated in a 7.5% (MMP-9, c-Jun) or 10% SDS polyacryl-
amide gel (ERK, p38, JNK, actin) with Tris-glycine–SDS running
buffer. After electrophoresis, proteins were transferred to polyvinyli-
dene difluoride membrane (Bio-Rad Laboratories). The membrane
was blocked with 5% nonfat dry milk in 0.1% Tween-20 (Sigma-
Aldrich Chemie GmbH, Buchs, Switzerland) in Tris-buffered saline
(milk/Tris-buffered saline) for 1 hour at room temperature. The blots
were incubated at 4°C overnight with primary antibodies against
JNK, p38, p44/p42 (ERK), c-Jun, MMP-9, and actin and phosphor-
ylated forms of JNK, p38, p44/p42, and c-Jun (supplemental Table I)
diluted in 5% bovine serum albumin (Sigma-Aldrich) in Tris-
buffered saline or milk/Tris-buffered saline followed by 1-hour
incubation at room temperature with secondary antibodies (supple-
mental Table I) in milk/Tris-buffered saline. Antibody–antigen
complexes were visualized by chemifluorescence using ECL Plus
Western Blotting Detection Reagents (Amersham Biosciences/GE
Healthcare, Piscataway, NJ) according to the manufacturer’s instruc-
tions and a Typhoon scanner (Amersham). Western blot scans were
quantified using Scion Image software (www.scioncorp.com).
Quantified optical densities on WBs of all intracellular proteins
were standardized to actin levels of the same samples, whereas
MMP-9, which is mostly extracellular, was standardized to the total
amounts of protein. For all phosphoproteins, two WBs were per-
formed and quantified: one with antibody detecting only the phos-
phorylated form of the protein and another with antibody detecting
both the phosphorylated and unphosphorylated form (total) (Figure
1A). Phosphorylation state was defined as the ratio between phos-
phorylated and total levels of the proteins of interest. Results are
expressed as arbitrary units where the mean of the unruptured group
is set at 1.00.
Statistical Analysis
Data were analyzed with SPSS for Windows (release 13.0; SPSS
Inc). Effects of rupture status, sex, and aneurysm size on protein and
phosphorylation levels were compared by t tests, analysis of vari-
ance, and covariance after logarithmic transformation of dependent
variables, which was necessary to obtain their normal distributions
and equality of variances between different groups. Correlation
between protein and phosphorylation levels and aneurysm size was
estimated using Spearman’s rank correlation coefficients (r). Effects
of interactions of rupture status, aneurysm size, sex, and age on
protein and phosphorylation levels were studied with 2-way analysis
of variance. Probability values less than 0.05 were considered
statistically significant.
Table 1. Patient and IA Characteristics
Variables
Unruptured IAs
(n12)
Ruptured IAs
(n12)
Patients
Mean age, years (range) 56.8 (43–71) 55.9 (39–82)
Women* 8 3
Aneurysms resected for study
Location
Middle cerebral artery 5 6
Internal carotid artery 3   
Anterior communicating artery 2 3
Basilar artery 1 1
Posterior communicating artery 1 1
Pericallosal artery    1
Largest diameter, meanSD, mm† 8.22.2 12.65.9
Largest diameter, median, mm (range) 8.0 (5.8–13) 10.5 (6.5–26)
Time from rupture to sample resection,
median (range)
   20.25 hours
(5.5 hours to
48 days)
*P0.041 for difference between groups, Pearson’s 2 test.
†P0.035 for difference between groups, Student’s independent samples
t test.
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Results
Mitogen-Activated Protein Kinases in Intracranial
Aneurysm Wall
First we studied whether there were activated MAPKs in IAs
and in which part of the wall they localized. The phosphorylated
forms of all 3 MAPKs were found both in unruptured and
ruptured IAs in immunofluorescent staining (Figure 2).
Phospho-ERK localized in the cytoplasm of -smooth muscle
actin (SMA)-positive cells and in some SMA-negative cells
in the outer and luminal side of the wall. Phospho-p38 localized
in the cytoplasm of most of and nuclei of some SMA-positive
cells. Few cells were also detected in the luminal and outer sides
of the IA wall. Phospho-JNK localized in the nuclei of SMA-
positive cells. Cytoplasm was also weakly positive. In the outer
IA wall, some SMA-negative cells stained positive for
phospho-JNK with or without positive nuclei. To conclude, the
Figure 1. Examples of WBs obtained in
unruptured and ruptured IAs (A). The
phosphorylation of p54 JNK was higher
in ruptured than in unruptured IAs (B)
and correlated with IA size (C). The lev-
els of phospho-p38 correlated with IA
size (C).
Figure 2. The immunofluorescent stain-
ing of a ruptured IA wall showing the
localization of phosphorylated MAPKs.
(A) ERK, (B) p38, and (C) JNK in green
and SMA in red; DAPI (blue) was used
as a nuclear stain. Asterisk indicates the
luminal side of the wall.
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majority of the phospho-MAPK signal was localized in the
SMA-positive cells in the IA wall and the staining pattern did
not differ between unruptured and ruptured IAs.
Mitogen-Activated Protein Kinases versus
Intracranial Aneurysm Rupture and Size
Because MAPKs were found in both unruptured and ruptured
IAs in the immunofluorescent staining, we studied the expres-
sion and phosphorylation of MAPKs more closely by WB
(Table 2). The levels or phosphorylation state of any of the
MAPKs were not affected by sex or age of the patients (data not
shown). First we investigated whether there is any difference
between unruptured and ruptured IAs. The total levels of 2
isoforms of JNK, namely p54 and p46, did not associate with the
rupture status. However, the phosphorylation state of p54 JNK
was significantly (P0.028) increased 1.5-fold in ruptured IAs
compared with unruptured ones (Figure 1B). Total levels of
ERK and p38 or their phosphorylation state did not associate
with IA rupture status in this analysis.
Next we tested whether the expression and phosphoryla-
tion of MAPKs correlate with IA size. The level of phospho-
p54 JNK and its phosphorylation state directly correlated
with IA size (r0.490, P0.015 and r0.501, P0.013,
respectively; Figure 1C) but the levels or the phosphorylation
state of p46 JNK did not. The levels of phosphorylated and
total p38 correlated with IA size (r0.506, P0.012 and
r0.592, P0.002, respectively; Figure 1D). ERK levels or
phosphorylation did not correlate with IA size.
As expected,17 ruptured IAs were larger than the unrup-
tured ones (Table 1). Hence, we wanted to study whether the
differences in the protein levels and phosphorylation of
p54 JNK as well as the differences in the protein levels of p38
are better explained by rupture status than by IA size.
The median size of all 24 IAs was 8.0 mm. The phosphor-
ylation state of p54 JNK was increased 1.5-fold in large IAs
when compared with small IAs (1.510.62 for large IAs
[8.0 mm in diameter, n12], 1.010.23 for small ones
[8.0 mm, n12], P0.037). The levels or phosphorylation
state of other MAPKs did not differ according to aneurysm
size.
By use of covariance analysis, it was revealed that aneu-
rysm size, but not rupture status, was significantly associated
with the level of phospho-p54 JNK (P0.027 and P0.894,
respectively). The phosphorylation of p54 JNK was also
associated with IA size but not with rupture status (P0.023
and P0.296, respectively). The levels of total p38 associ-
ated with IA size but not with rupture status (P0.003 and
0.210, respectively). On the other hand, the levels of
phospho-p38 were associated both with IA size and with
rupture status (P0.001 and P0.027, respectively). How-
ever, although the levels of phospho-p38 increased with
increasing aneurysm size, they were lower in ruptured IAs.
There were no significant interactions between rupture status
or aneurysm size and the levels or phosphorylation state of
any of the MAPKs.
c-Jun Expression in the Intracranial
Aneurysm Wall
Because JNK associated with IA size and is an important
signaling molecule in the pathogenesis of many vascular
diseases, the study of JNK signaling was continued by
analyzing the levels and the phosphorylation state of tran-
scription factor c-Jun. The phosphorylation state and the
phosphorylated and total levels of p54 JNK correlated with
the phosphorylated and total levels of c-Jun (Table 3) but not
with the phosphorylation state of c-Jun (data not shown). The
phosphorylated p46 JNK also correlated with the phosphor-
ylated and total levels of c-Jun (Table 3). A trend level
increase was observed in phospho-c-Jun and total c-Jun levels
(1.7-fold and 1.8-fold, respectively) in ruptured IAs as com-
pared with unruptured (Table 2). The levels of c-Jun did not
correlate with IA size, but there was a trend (P0.067) for
increase in the levels of phospho-c-Jun in large IAs compared
with small IAs.
Matrix Metalloproteinase-9
Because the JNK pathway was shown to be active in large
IAs, we were also interested in studying some possible
mechanism that may directly affect the IA size. One possi-
bility of how JNK and c-Jun could regulate IA size is by
Table 2. Protein Levels in the IA Wall
Proteins
Unruptured IAs
(meanSD)
Ruptured IAs
(meanSD) P
Phospho-p54 JNK 1.000.30 1.481.01 NS
Total p54 JNK 1.000.21 0.960.40 NS
Phospho-p54/total p54 JNK ratio 1.000.23 1.520.61 0.028
Phospho-p46 JNK 1.000.24 1.441.01 NS
Total p46 JNK 1.000.23 1.661.12 0.081
Phospho-p46/total p46 JNK ratio 1.000.15 0.900.25 NS
Phospho-p38 1.000.28 0.970.46 NS
Total p38 1.000.28 1.090.40 NS
Phospho-p38/total p38 ratio 1.000.14 0.900.21 NS
Phospho-ERK 1.000.24 1.040.70 NS
Total ERK 1.000.12 1.160.56 NS
Phospho-ERK/total ERK ratio 1.000.19 0.850.27 NS
Phospho-c-Jun 1.000.46 1.691.06 0.066
Total c-Jun 1.000.50 1.821.28 0.052
Phospho-c-Jun/total c-Jun ratio 1.000.30 0.950.22 NS
MMP-9 1.000.43 4.343.29 0.001
Student’s independent samples t test.
NS indicates not significant.
Table 3. Correlation Between JNK and c-Jun
Variables Phospho-c-Jun Total c-Jun
Phospho-p54 JNK 0.657* 0.585*
Total p54 JNK 0.426† 0.458†
Phospho-p54/total p54 JNK ratio 0.533* 0.420†
Phospho-p46 JNK 0.576* 0.536*
Total p46 JNK 0.375‡ 0.463†
Phospho-p46/total p46 JNK ratio 0.213 0.038
*P0.01, †P0.05, ‡P0.071, Spearman’s rho correlation analysis.
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affecting the expression of MMPs.18 MMPs have been
associated with tissue remodeling and degradation in the
normal vessel wall as well as in IA wall.19 Thus, we studied
pro-MMP-9 levels in IAs and the correlation of pro-MMP-9
expression with JNK activation. MMP-9 levels were in-
creased 4.3-fold in ruptured IAs compared with unruptured
IAs (Table 2; Figure 3B), but they did not correlate with IA
size in correlation analysis. However, MMP-9 levels were
2.6-fold higher in large IAs as compared with small IAs
(3.853.42 versus 1.491.54, P0.014). In the covariance
analysis, elevated MMP-9 levels highly associated with the
IA rupture status but not with IA size (P0.001 and
P0.385, respectively). Interestingly, MMP-9 levels also
correlated with the phosphorylation of p54JNK in unruptured
but not in ruptured IAs (r0.797, P0.002 and r0.266,
P0.404, respectively) suggesting that MMP-9 expression is
at least partly regulated by JNK (Figure 3C).
Discussion
In this study, we investigated 3 key MAPKs in the human IA
wall. The immunofluorescent stainings showed that active
forms of all 3 key MAPKs are found in both ruptured and
unruptured IAs and are mainly localized in the SMCs.
MAPKs have different kinds of roles within the intracellular
signaling pathways; ERKs respond to mitogenic stimuli,
whereas JNKs and p38s are activated mainly by stress
signaling.9 To verify the activation status, the phosphoryla-
tion state and the levels of each of these 3 MAPKs were
studied separately by WB. The results suggest active roles of
stress-activated kinases, JNK and p38, in the IA wall.
Possible Activators of Stress-Activated Kinases in
Intracranial Aneurysms
JNK and p38 are activated in response to cellular and
environmental stresses such as inflammatory cytokines and
shear stress.9 IAs tend to develop at the sites of high shear
stress20 and thus hemodynamic factors may play a role in
activating JNK and p38 in IAs. Inflammation is also associ-
ated with the pathogenesis of IAs.5–7 The levels of tumor
necrosis factor-, a cytokine secreted by inflammatory cells,
have been previously shown to be increased in ruptured IAs.21
Interestingly, tumor necrosis factor- is one of the activators
of JNK and p38.22,23
The Role of Stress-Activated Kinases in Growth
and Rupture of Intracranial Aneurysms
Phosphorylation of p54 JNK was associated more highly with
IA size than with the rupture status, which suggests that the
activation of p54 JNK is not a response to the rupture but is
involved in the pathogenesis of IA and its growth before
rupture. The levels of phosphorylated and total p38 directly
associated with the aneurysm size. It is known that the
increase in IA size associates with elevated rupture risk.17 The
pathways that are active in large IAs, like JNK and p38
signaling pathway, may be involved in the inter- and intra-
cellular mechanisms that result in a weaker IA wall being
more prone to rupture. However, these may also act as
survival and repair pathways that are activated in the weak-
ened IA wall to prevent the IA rupture. It has been observed
in vitro and in animal experiments that p38 is activated in
cerebral arteries after subarachnoid hemorrhage leading to the
development of vasospasm.24 However, in our samples, the
levels of phospho-p38 were slightly lower in ruptured IAs.
The reason for this discrepancy and the implications of this
phenomenon require further investigation.
Traditionally, JNK has been seen as a proapoptotic and p38
as a proinflammatory signaling molecule.9,25 Stress-activated
kinases may also regulate cell growth and survival. For
example, stretch can cause the activation of both JNK and
p38 in SMCs followed by the induction of SMC actin
expression.26 Clearly, stress-activated MAPKs have different
roles depending on the cell type and stimuli and these
signaling pathways may also have combinatory effects on the
cell function. Thus, the stress-activated MAPK pathways
within IAs should be studied more closely to clarify their
roles in the pathogenesis of IAs.
Extracellular Signal-Regulated Kinase in
Intracranial Aneurysms
ERKs are activated in response to growth and mitogenic
stimuli and they are not associated with stress signaling like
JNKs and p38s.9 In our study, the expression and phosphor-
ylation of ERK did not associate with the size or the rupture
status of IAs, which further supports the view that IA wall
remodeling is a pathological process in which stress-activated
pathways have a role in determining how cells behave.
Figure 3. WBs showing pro-MMP-9 (92 kDa) (A). MMP-9 levels
were higher in ruptured than unruptured IAs (B) and correlated
with the phosphorylation of p54 JNK in unruptured (white cir-
cles) but not in ruptured (black circles) IAs (C).
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Downstream Signaling of c-Jun
N-Terminal Kinase
It has recently been shown that JNK has an important role in
the pathogenesis of abdominal aortic aneurysms.14 In that
study JNK was shown to program gene expression patterns
that enhanced the degradation of the extracellular matrix (eg,
increase in MMP-9 expression) and suppressed biosynthetic
enzymes, resulting in the destruction of the tissue. JNK
inhibition led to the reduced levels of phospho-c-Jun and to
enhanced tissue repair. We show here that the levels of
phospho-c-Jun and c-Jun correlate with the levels of
phospho-JNK in the IA wall, which implies that the JNK
pathway is also activated in IAs. c-Jun is one of the AP-1
group proteins and JNK can activate c-Jun by 2 mechanisms:
by increasing the expression of c-Jun and by phosphorylating
c-Jun.22 c-Jun itself has diverse biological functions like
controlling cell proliferation, differentiation, and apoptosis.
In SMCs, c-Jun is involved in SMC proliferation and intimal
thickening.27
Previously it has been observed that MMP-9 expression
and the proteolytic activity of MMPs and serine proteinases
are increased in IAs.19,28 We showed that the phosphorylation
of p54JNK positively correlated with MMP-9 levels in
unruptured IAs and that MMP-9 was highly upregulated in
ruptured aneurysms. However, in some ruptured aneurysms,
there were high MMP-9 levels without increased JNK levels,
which indicate that also other mechanisms are affecting
MMP-9 expression.
Mitogen-Activated Protein Kinases and the
Treatment of Intracranial Aneurysms
Pharmaceutical treatment of IAs is a future goal and, for
example, endovascular coils with growth factors have been
already tested in animal models.29 JNK inhibitors have been
suggested for the treatment of abdominal aortic aneurysms
and p38 inhibitors for the treatment of inflammatory diseases
like rheumatoid arthritis and also atherosclerosis.14,30 Future
studies may clarify the specific roles of MAPKs in the
pathogenesis of IAs and show how drugs that modulate
MAPK signaling affect the IA wall.
Limitations and Strengths of the Study
Our samples were freshly frozen and thus very reliable for
studies of phosphoproteins known to be subject to rapid
dephosphorylation after tissue harvest or postmortem. How-
ever, because normal fresh human circle of Willis artery
samples are extremely difficult to obtain, we did not have any
normal arterial controls. It would be interesting to see how
signaling pathways in IAs differ from normal intracranial
arterial wall. In WB, we used homogenized samples and, of
course, there may be local differences in the amounts of
signaling proteins within the IA wall. However, quantitative
analysis of such ubiquitous proteins is practically impossible
using other methods like immunohistochemistry. Based on
histological analysis, acellular or highly thrombosed samples
were excluded from the study because the aim was to study
intracellular signaling proteins within IA wall. Also, because
IA samples were heavily denatured to preserve the phosphor-
ylation state of the proteins, we could not study MMP-9 using
zymography, which would provide information about the
activity of MMP-9.
Summary
All 3 MAPKs, JNK, p38, and ERK, were found both in
unruptured and ruptured IAs. The levels of phospho-p54JNK
and the phosphorylation state of p54 JNK associated with IA
size and possibly with rupture status. The levels of phospho-
p38 and the levels of total p38 associated with the aneurysm
size. ERK did not associate with the rupture status or the
aneurysm size. Furthermore, the phosphorylation state and
the phosphorylated and total levels of JNK correlated with the
phosphorylated and total levels of c-Jun, and there was a
trend for increase in the levels of phospho-c-Jun and total
c-Jun in the ruptured IAs as compared with unruptured ones.
MMP-9 levels associated with the rupture status and MMP-9
levels correlated with the phosphorylation of p54 JNK in
unruptured but not in ruptured IAs.
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